Impact of revised definitions for extensively drug-resistant TB on disease classification

被引：2

作者：

Shin, J. E. ^{[1
]}

Jo, K-W. ^{[1
,2
]}

O, Y. J. ^{[1
]}

Jeon, D. ^{[3
]}

Kang, H. ^{[4
]}

Yim, J-J. ^{[5
]}

Kwon, Y-S. ^{[6
]}

Shim, T. S. ^{[1
,2
]}

机构：

[1] Asan Med Ctr, Div Pulm & Crit Care Med, Seoul, South Korea

[2] Univ Ulsan, Div Pulm & Crit Care Med, Coll Med, Seoul, South Korea

[3] Pusan Natl Univ, Dept Internal Med, Yangsan Hosp, Yangsan, South Korea

[4] Masan Natl TB Hosp, Dept Chest Med, Masan, South Korea

[5] Seoul Natl Univ, Div Pulm & Crit Care Med, Dept Internal Med, Coll Med, Seoul, South Korea

[6] Chonnam Natl Univ Hosp, Dept Internal Med, Gwangju, South Korea

来源：

INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE | 2021年 / 25卷 / 09期

关键词：

MULTIDRUG-RESISTANT; TUBERCULOSIS;

D O I：

10.5588/ijtld.21.0229

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：766 / 768

页数：3

共 13 条

[1] A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis [J].

Andries, K ;

Verhasselt, P ;

Guillemont, J ;

Göhlmann, HWH ;

Neefs, JM ;

Winkler, H ;

Van Gestel, J ;

Timmerman, P ;

Zhu, M ;

Lee, E ;

Williams, P ;

de Chaffoy, D ;

Huitric, E ;

Hoffner, S ;

Cambau, E ;

Truffot-Pernot, C ;

Lounis, N ;

Jarlier, V .

SCIENCE, 2005, 307 (5707) :223-227

[2]

[Anonymous], 2013, The use of Bedaquiline in the treatment of m ultidrug-resistant tuberculosis. Interim policy guidance

[3] Linezolid for the treatment of multidrug-resistant, gram-positive infections: Experience from a compassionate-use program [J].

Birmingham, MC ;

Rayner, CR ;

Meagher, AK ;

Flavin, SM ;

Batts, DH ;

Schentag, JJ .

CLINICAL INFECTIOUS DISEASES, 2003, 36 (02) :159-168

[4] Linezolid for the treatment of complicated drug-resistant tuberculosis: a systematic review and meta-analysis [J].

Cox, H. ;

Ford, N. .

INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2012, 16 (04) :447-454

[5] Multidrug-Resistant Tuberculosis and Culture Conversion with Bedaquiline [J].

Diacon, Andreas H. ;

Pym, Alexander ;

Grobusch, Martin P. ;

de los Rios, Jorge M. ;

Gotuzzo, Eduardo ;

Vasilyeva, Irina ;

Leimane, Vaira ;

Andries, Koen ;

Bakare, Nyasha ;

De Marez, Tine ;

Haxaire-Theeuwes, Myriam ;

Lounis, Nacer ;

Meyvisch, Paul ;

De Paepe, Els ;

van Heeswijk, Rolf P. G. ;

Dannemann, Brian .

NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (08) :723-732

[6]

Kent PT, 1985, Public health mycobacteriology: a guide for the level III laboratory

[7] Linezolid for Treatment of Chronic Extensively Drug-Resistant Tuberculosis [J].

Lee, Myungsun ;

Lee, Jongseok ;

Carroll, Matthew W. ;

Choi, Hongjo ;

Min, Seonyeong ;

Song, Taeksun ;

Via, Laura E. ;

Goldfeder, Lisa C. ;

Kang, Eunhwa ;

Jin, Boyoung ;

Park, Hyeeun ;

Kwak, Hyunkyung ;

Kim, Hyunchul ;

Jeon, Han-Seung ;

Jeong, Ina ;

Joh, Joon Sung ;

Chen, Ray Y. ;

Olivier, Kenneth N. ;

Shaw, Pamela A. ;

Follmann, Dean ;

Song, Sun Dae ;

Lee, Jong-Koo ;

Lee, Dukhyoung ;

Kim, Cheon Tae ;

Dartois, Veronique ;

Park, Seung-Kyu ;

Cho, Sang-Nae ;

Barry, Clifton E., III .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (16) :1508-1518

[8] Effect of bedaquiline on mortality in South African patients with drug-resistant tuberculosis: a retrospective cohort study [J].

Schnippel, Kathryn ;

Ndjeka, Norbert ;

Maartens, Gary ;

Meintjes, Graeme ;

Master, Iqbal ;

Ismail, Nazir ;

Hughes, Jennifer ;

Ferreira, Hannetjie ;

Padanilam, Xavier ;

Romero, Rodolfo ;

te Riele, Julian ;

Conradie, Francesca .

LANCET RESPIRATORY MEDICINE, 2018, 6 (09) :699-706

[9]

WHO, 2016, GLOB TUB REP 2016

[10]

World Health Organization, 2019, RAPID COMMUNICATION

← 1 2 →